/Companies

Yseop

5 known investors

Find your way into Yseop

Sign up to see every warm intro you have to Yseop

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Yseop team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Yseop provides an AI-powered platform that automates medical writing and regulatory reporting tasks for life sciences teams, accelerating document submission timelines within the CTD pyramid framework. The platform uses neuro-symbolic AI to transform complex documentation workflows and ensure compliance in pharmaceutical regulatory processes.

Founders & leadership

EWEmmanuel Walckenaer
Emmanuel WalckenaerCEOEmmanuel Walckenaer is CEO of Yseop, which provides an AI-powered platform for automating medical writing and regulatory reporting in the pharmaceutical industry. He has prior experience in healthcare, IoT, artificial intelligence, and wireless sectors, with expertise in sales, business strategy, and mergers and acquisitions.

Investors · 5

Also in the syndicate · 3

Eli LillyNextStage AMNovartis (dRx Capital)

Funding

SEC filings, press & company announcements
  • Undisclosed amountstrategic investment roundDec 2023

    Eli Lilly, NextStage AM, Novartis (dRx Capital), Wille Finance

    Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does Yseop do?
Yseop provides an AI-powered platform that automates medical writing and regulatory reporting tasks for life sciences teams, accelerating document submission timelines within the CTD pyramid framework. The platform uses neuro-symbolic AI to transform complex documentation workflows and ensure compliance in pharmaceutical regulatory processes.
Who are Yseop's investors?
Yseop's investors include Claret Capital Partners, Wille Finance.